Patents by Inventor Greg Gambetta

Greg Gambetta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polypeptides having aminolevulinic acid activity and nucleic acids encoding same
    Patent number: 6207433
    Abstract: The present invention relates to isolated polypeptides having 5-aminolevulinic acid synthase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: January 4, 2000
    Date of Patent: March 27, 2001
    Assignee: Novo Nordisk Biotech, Inc.
    Inventor: Greg Gambetta
  • Polypeptides having 5-aminolevulinic acid synthase activity and nucleic acids encoding same
    Patent number: 6033892
    Abstract: The present invention relates to isolated polypeptides having 5-aminolevulinic acid synthase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: November 16, 1998
    Date of Patent: March 7, 2000
    Assignee: Novo Nordis Biotech, Inc.
    Inventor: Greg Gambetta